Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Pediatrics
|
January 1, 1994
Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia
E C Guinan, K D Lopez, R D Huhn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1987
Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues
R D Huhn, M R Posner, S I Rayter, et al.
Human Gene Therapy
|
August 14, 1999
Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning
R D Huhn, J F Tisdale, B Agricola, et al.
Cancer Research
|
May 15, 1990
Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4
S R Lasky, W Bell, R D Huhn, et al.
Pharmaceutical Research
|
January 19, 1999
Pharmacokinetics and leukocyte responses of recombinant human interleukin-10
E Radwanski, A Chakraborty, S Van Wart, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, J Gallo, et al.
Blood
|
January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, S M O'Connell, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1995
Pharmacodynamics of daily subcutaneous recombinant human interleukin-3 in normal volunteers
R D Huhn, E J Yurkow, J G Kuhn, et al.
Experimental Hematology
|
June 1, 1996
Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers
R D Huhn, E J Yurkow, R Tushinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy
W L Furman, D L Fairclough, R D Huhn, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Pediatrics
|
January 1, 1994
Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia
E C Guinan, K D Lopez, R D Huhn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1987
Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues
R D Huhn, M R Posner, S I Rayter, et al.
Human Gene Therapy
|
August 14, 1999
Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning
R D Huhn, J F Tisdale, B Agricola, et al.
Cancer Research
|
May 15, 1990
Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4
S R Lasky, W Bell, R D Huhn, et al.
Pharmaceutical Research
|
January 19, 1999
Pharmacokinetics and leukocyte responses of recombinant human interleukin-10
E Radwanski, A Chakraborty, S Van Wart, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1997
Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, J Gallo, et al.
Blood
|
January 15, 1996
Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers
R D Huhn, E Radwanski, S M O'Connell, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1995
Pharmacodynamics of daily subcutaneous recombinant human interleukin-3 in normal volunteers
R D Huhn, E J Yurkow, J G Kuhn, et al.
Experimental Hematology
|
June 1, 1996
Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers
R D Huhn, E J Yurkow, R Tushinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy
W L Furman, D L Fairclough, R D Huhn, et al.
Page
of 3